Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat
Understanding these comparisons helps you appreciate why ipamorelin is often the first choice for growth hormone optimization
[PMID: 18819487] PubMed record related to this compound for laboratory literature review
This blog aims to address two of the most asked questions: What are MTHFR mutations? and What are MTHFR symptoms? Well also explore testing for this mutation and the significance of methylated vitamins
3 Thyroidbrain axis pathophysiology and neurological manifestations The major mechanistic routes linking thyroid dysfunction to neuropsychiatric manifestations are summarized in Figure 2, highlighting disrupted hormone transport/activation in the brain, neurotransmitter imbalance, oxidative stressneuroinflammation, and bloodbrain barrier vulnerability
Some research suggests a reduced carbohydrate diet (84 g/day) may be associated with better outcomes in Crohns disease (Lorenz-Meyer 1996)